ORBIT Bleeding Score Calculator
Bleeding risk assessment
Select each clinical feature present. The score updates automatically.
The published rates are observed group-level rates per 100 patient-years, not an individualized prediction or a guarantee of an individual patient's annual risk.
About the ORBIT score
The ORBIT bleeding score was developed to estimate major bleeding risk in patients with atrial fibrillation receiving oral anticoagulation. It uses five clinical factors that are generally available in routine care.
Components and points
| Factor | Criterion | Points |
|---|---|---|
| Older age | Age ≥75 years | 1 |
| Reduced hemoglobin / anemia | Low hemoglobin/hematocrit or history of anemia | 2 |
| Bleeding history | History of bleeding | 2 |
| Impaired kidney function | eGFR <60 mL/min/1.73 m² | 1 |
| Antiplatelet treatment | Concurrent antiplatelet therapy | 1 |
Risk categories in the derivation cohort
| Score | Category | Observed major bleeding rate |
|---|---|---|
| 0–2 | Low | 2.4 per 100 patient-years |
| 3 | Medium | 4.7 per 100 patient-years |
| 4–7 | High | 8.1 per 100 patient-years |
Clinical use and limitations
ORBIT supports bleeding-risk assessment but should not be used alone to decide whether to start or withhold oral anticoagulation. Assess modifiable risk factors, drug interactions, renal function, anemia, prior bleeding, and the patient's thromboembolic risk and preferences.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.